RESEARCH TRIAL: Synthetic Growth Hormone in Patients with Multiple System Atrophy

[Guest guest]

This is the clinical trial that Jill in the UK was telling us about. (From

the Matheson Trust website - newsletter section)

Regards,

Pam

----------------

A Trial of Synthetic Growth Hormone in Patients with Multiple System Atrophy

A new trial is about to begin at the Institute of Neurology, Queen Square,

London, under the supervision of Professor Niall Quinn. The aim of this

trial is to investigate whether or not synthetic human Growth Hormone has a

useful effect in patients with Multiple System Atrophy. We are looking for

patients between 30 and 75 years of age who have been diagnosed with MSA. If

you are interested in the study and wish to receive further information,

please contact:

Professor N. Quinn, Institute of Neurology, Queen Square, London WC1N 3BG

(ph: 0 ext 4253) or Dr Bozi/ Dr Noemi Russo Clinical

research Fellows of Professor Quinn at the same address (ph: 0

ext 4124)

[Guest guest]

Just an update on 's participation in the tests. We attended last

Monday for initial tests, we were seen by two VERY YOUNG doctors who asked

many questions, one of the tests involved holding his arms out fully,

his right thumb trembled a little - so does mine in this position - and the

girls decided had got parkinsons not MSA. I just give up with some of

these people. They admitted they were not sure and would have to contact

s professors and they would come back to us shortly.... so that is

where we stand, as yet we are not sure if is going to take part or

not.

JILL

RESEARCH TRIAL: Synthetic Growth Hormone in Patients with

Multiple System Atrophy

This is the clinical trial that Jill in the UK was telling us about. (From

the Matheson Trust website - newsletter section)

Regards,

Pam

----------------

A Trial of Synthetic Growth Hormone in Patients with Multiple System

Atrophy

A new trial is about to begin at the Institute of Neurology, Queen Square,

London, under the supervision of Professor Niall Quinn. The aim of this

trial is to investigate whether or not synthetic human Growth Hormone has a

useful effect in patients with Multiple System Atrophy. We are looking for

patients between 30 and 75 years of age who have been diagnosed with MSA.

If

you are interested in the study and wish to receive further information,

please contact:

Professor N. Quinn, Institute of Neurology, Queen Square, London WC1N 3BG

(ph: 0 ext 4253) or Dr Bozi/ Dr Noemi Russo Clinical

research Fellows of Professor Quinn at the same address (ph: 0

ext 4124)

If you do not wish to belong to shydrager, you may

unsubscribe by sending a blank email to

shydrager-unsubscribe